Bioenzym 2G
Clinical Results Available:
The efficacy of Bioenzym 2G was clearly proven in scientific studies (see bibliography). For example, through December 2008, 100 patients with prostate cancer who had received therapy with Bioenzym 2G were included within the framework of a multinational study. Approximately 70% of the patients showed a clear cancer growth regression, with more than 50% reduction or even normalization of the tumor marker (PSA). In about one-third of all the patients, there was an improvement in general well-being, related to increased appetite and weight gain. In addition, all the patients who, prior to treatment with Bioenzym 2G, had complained of typical cancer-related pain, noted a marked diminishment of the same.
